The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Bruno Andrioletti - One of the best experts on this subject based on the ideXlab platform.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
ChemInform, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:A New mild and environmental friendly benzylic oxidation with good to excellent yields is presented.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
Tetrahedron Letters, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:Abstract A New and efficient methodology was developed for the selective benzylic C–H oxidation using tert- butyl hydroperoxide as the oxidant and Fe(TAML)Li as the catalyst. The oxidation of various simple benzylic compounds was carried out with good to excellent yields and/or selectivity. A plausible mechanism for the reaction is proposed.
Michael A Perelman - One of the best experts on this subject based on the ideXlab platform.
-
original research psychology a New Combination treatment for premature ejaculation a sex therapist s perspective
The Journal of Sexual Medicine, 2006Co-Authors: Michael A PerelmanAbstract:ABSTRACT Perelman MA. A New Combination treatment for premature ejaculation: A sex therapist’s perspective. J Sex Med 2006;3:1004–1012 This article describes the diagnosis and treatment of premature ejaculation (PE) from a sex therapist’s perspective and proposes that Combination therapy integrating sex therapy and sexual pharmaceuticals is frequently the best treatment approach. Failure to appreciate the multimodal etiology and pathophysiology of PE makes the condition more difficult to diagnose and treat. Many physicians have tried pharmacologic approaches, but are limited to providing topical anesthetics or suggesting off‐label uses of antidepressant and erectile dysfunction medications, because no medication is currently indicated specifically for PE. Furthermore, patients frequently relapse after discontinuation of the pharmaceutical. Sex therapists appreciate the multidimensional nature of PE for the patient and partner, but few patients seek out this approach, which is labor‐intensive and often lacking long‐term follow‐up success. Most men with PE are not receiving treatment, secondary to their embarrassment about discussing their condition and a lack of clinician inquiry about sexual dysfunction. Even for those who do engage in discussion, diagnoses may be inconsistent, because a universally accepted definition of the condition and diagnostic criteria are nonexistent. Men with PE experience anxiety and lack sexual self‐confidence; subsequently, their sexual and overall relationship frequently suffer. Because PE involves psychosocial and physiologic factors, treatment that addresses both should yield the best balance of function. There is interest in New agents designed specifically for PE to provide an improved pharmacotherapeutic opportunity. Yet, a Combination treatment integrating pharmaceuticals and sex therapy would provide an optimized approach. Besides increasing coital latency directly, sexual pharmaceuticals could be used to provide greater opportunity for men to recognize their premonitory sensations to ejaculation more readily, facilitating a “choice point”, which is key to facilitating behavioral change and learning. Such a Combination approach would result in prolonged ejaculatory latency, improved treatment satisfaction, and superior long‐term outcome.
-
original research psychology a New Combination treatment for premature ejaculation a sex therapist s perspective
The Journal of Sexual Medicine, 2006Co-Authors: Michael A PerelmanAbstract:This article describes the diagnosis and treatment of premature ejaculation (PE) from a sex therapist's perspective and proposes that Combination therapy integrating sex therapy and sexual pharmaceuticals is frequently the best treatment approach. Failure to appreciate the multimodal etiology and pathophysiology of PE makes the condition more difficult to diagnose and treat. Many physicians have tried pharmacologic approaches, but are limited to providing topical anesthetics or suggesting off-label uses of antidepressant and erectile dysfunction medications, because no medication is currently indicated specifically for PE. Furthermore, patients frequently relapse after discontinuation of the pharmaceutical. Sex therapists appreciate the multidimensional nature of PE for the patient and partner, but few patients seek out this approach, which is labor-intensive and often lacking long-term follow-up success. Most men with PE are not receiving treatment, secondary to their embarrassment about discussing their condition and a lack of clinician inquiry about sexual dysfunction. Even for those who do engage in discussion, diagnoses may be inconsistent, because a universally accepted definition of the condition and diagnostic criteria are nonexistent. Men with PE experience anxiety and lack sexual self-confidence; subsequently, their sexual and overall relationship frequently suffer. Because PE involves psychosocial and physiologic factors, treatment that addresses both should yield the best balance of function. There is interest in New agents designed specifically for PE to provide an improved pharmacotherapeutic opportunity. Yet, a Combination treatment integrating pharmaceuticals and sex therapy would provide an optimized approach. Besides increasing coital latency directly, sexual pharmaceuticals could be used to provide greater opportunity for men to recognize their premonitory sensations to ejaculation more readily, facilitating a "choice point", which is key to facilitating behavioral change and learning. Such a Combination approach would result in prolonged ejaculatory latency, improved treatment satisfaction, and superior long-term outcome.
François Napoly - One of the best experts on this subject based on the ideXlab platform.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
ChemInform, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:A New mild and environmental friendly benzylic oxidation with good to excellent yields is presented.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
Tetrahedron Letters, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:Abstract A New and efficient methodology was developed for the selective benzylic C–H oxidation using tert- butyl hydroperoxide as the oxidant and Fe(TAML)Li as the catalyst. The oxidation of various simple benzylic compounds was carried out with good to excellent yields and/or selectivity. A plausible mechanism for the reaction is proposed.
Raphaelle Kieffer - One of the best experts on this subject based on the ideXlab platform.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
ChemInform, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:A New mild and environmental friendly benzylic oxidation with good to excellent yields is presented.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
Tetrahedron Letters, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:Abstract A New and efficient methodology was developed for the selective benzylic C–H oxidation using tert- butyl hydroperoxide as the oxidant and Fe(TAML)Li as the catalyst. The oxidation of various simple benzylic compounds was carried out with good to excellent yields and/or selectivity. A plausible mechanism for the reaction is proposed.
Micheline Draye - One of the best experts on this subject based on the ideXlab platform.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
ChemInform, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:A New mild and environmental friendly benzylic oxidation with good to excellent yields is presented.
-
fe taml li tert butyl hydroperoxide as a New Combination for benzylic c h oxidation
Tetrahedron Letters, 2015Co-Authors: François Napoly, Raphaelle Kieffer, Micheline Draye, Ludivine Jeangerard, Catherine Gouxhenry, Bruno AndriolettiAbstract:Abstract A New and efficient methodology was developed for the selective benzylic C–H oxidation using tert- butyl hydroperoxide as the oxidant and Fe(TAML)Li as the catalyst. The oxidation of various simple benzylic compounds was carried out with good to excellent yields and/or selectivity. A plausible mechanism for the reaction is proposed.
